---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

secured: "gdkpv7czV9hU29i2VnaSv3euKfbAKxlFa5KT4NUCtDz6IrqYGm8W8B9zgLyEkVGj4xiqGOo9KpM+CN9vEbeTWDfg8UfAriFUhoczE05+ABtlUWWNIf/wDkBeORWbEH+0izh0O8dKp6WWEKSEtAr3ea2KxCuUOdCIfQmQqxxOyg5b7Oedlcub7Hn8/XUx9H2Clh5zlwNMP5fKThwpqcR7B2SvU9lTBr8JBz/49i4macoisIoQc+5k9dILjZXCsCd52G6dLCYN28zVVCmhbOyNNva5Mjtjp8IWXxtwQgesC6rL5WkUOkQjL8VBKgLA65Jf;TDdcdEAGxkxZxhK6vm3qyw=="
---

